Cadista Holdings Inc.

company.status.inactive

CIK 1521762fmd_1W0PRB7R1DADAQRMMZP4H65FYDManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Apr 01, 2009 to Sep 30, 2014, 20 periods

Income Statement · Annual · Millions · USD
Line item	FY2010	FY2011	FY2012	FY2013	FY2014
Total revenues	29	42	91	115	108
Cost of revenue	22	27	35	42	52
Gross profit	7	15	56	73	56
Research and development	2	1	0	0	0
Selling, general and administrative	4	4	5	6	8
Total operating expenses	6	6	6	8	10
Operating income	0	8	50	64	46
Interest expense	–	0	0	0	0
Interest and investment income	–	0	0	1	2
Other non-operating income (expense)	(0)	(0)	0	1	2
Income before taxes	0	8	50	65	48
Income tax expense	(5)	1	17	25	18
Net income from continuing operations	5	7	33	40	30
Net income	5	7	33	40	30